RAC 5.59% $1.70 race oncology ltd

40c valuation, page-8

  1. 431 Posts.
    lightbulb Created with Sketch. 33
    This is a gem of a stock, tight register and right sector. This is just the beginning too cheap right now, punters slowly catching on to its potential. Phase 2 trial success, with possible FDA clearance to phase 3 at only $11m market cap. Peer comparison puts this fair value above $60m market cap at least all imo dyor.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.